Imaging Diagnostic Systems sells laser mammography systems in Italy and
11 October 2005
Fort Lauderdale, Fla, USA. Imaging Diagnostic Systems, Inc., has
announced today the sale and shipment of a CT Laser Mammography (CTLM)(R)
system to Italy. The shipment marks the third CTLM sale in Italy and the
fifth system in the country. Italy has been an early adopter of the new CT
laser breast imaging technology in both research and clinical settings.
"IDSI has been sponsoring clinical studies in Italy since mid 2004. As a
result of those efforts, the acceptance of CT laser breast imaging in the
country is growing," stated Tim Hansen, IDSI Chief Executive Officer.
In Poland, the company's distributor, EDO MED. Sp. z.o.o., in August
purchased the two CT Laser Mammography systems installed for use in clinical
research projects at the Institute of Oncology, Center of Oncology, of the
Maria Sklodowska-Curie Memorial Institute in Gliwice. The sales mark IDSI's
expansion into the Polish market.
Tim Hansen, IDSI Chief Executive Officer, commented, "The research
projects we began with the Institute of Oncology, with currently over 400
cases completed in six months, will continue to conclusion. We expect that
our global commercialization program will follow this pattern, one of
regional clinical investigations followed by local area sales."
Mr. Jaroslaw Borkulak, President of EDO MED, stated, "We think that CTLM,
which represents new laser optical technology, is being accepted in the
Polish market. This technology highly complements our product basket of
innovative molecular and functional imaging products. CTLM is especially
important at this point because Poland has signed an unprecedented $1
billion National Cancer Program. This 10-year national initiative will allow
a significant improvement of Polish Cancer Care through screening,
diagnostic and therapeutic programs with capital investments. EDO MED is
well positioned in this oncology segment."